FDAFDA recall D-0840-2026 · Sep 9, 2026
American Health Packaging: Buprenorphine Sublingual Tablets (C-III) recall
Quick answer
- Product
- Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
- Brand
- American Health Packaging
- Codes, lots and dates
- Lot # 1030023, Exp Date: 06/30/2027.
- Hazard
- Labeling: Label Mix-up
- Distribution
- US Nationwide.
- Quantity
- 10,953 cartons.
- Recall date
- Sep 9, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- D-0840-2026
Recall found
Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Reason for recall
Labeling: Label Mix-up
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Quantity | 10,953 cartons. |
|---|---|
| Codes, lots and dates | Lot # 1030023, Exp Date: 06/30/2027. |
| Distribution | US Nationwide. |
| Recall date | Sep 9, 2026 |
| Class | Class III |
| Agency ID | D-0840-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class III: use of or exposure to the product is not likely to cause health problems.
- Status
- Ongoing
- Codes, lots and dates
- Lot # 1030023, Exp Date: 06/30/2027.
- Quantity
- 10,953 cartons.
- Distribution
- US Nationwide.
- Recalling firm
- American Health Packaging, Columbus, OH
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-08-19
Source: openFDA enforcement record D-0840-2026 · search recall number D-0840-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11). Brand: American Health Packaging Codes, lots and dates: Lot # 1030023, Exp Date: 06/30/2027.
What is the hazard?
Labeling: Label Mix-up
How do I check if mine is affected?
Codes, lots and dates: Lot # 1030023, Exp Date: 06/30/2027.
Where was it distributed?
US Nationwide.
Related recalls
- American Health Packaging: Cyanocobalamin Injection recall
- American Health Packaging: Metoclopramide Tablets recall
- Greenwich: Compounded sterile products
- Breckenridge Pharmaceutical, Inc.: Propranolol Hydrochloride Extended-Release Capsules, USP, 60mg
- React Health dba 3B Medical, Inc.: Bilevel Positive Airway Pressure (BPAP) System
- Rocky Mountain Nutrition, LLC: Santa Cruz Paleo Pineapple Caffeine and Island Punch Caffeine Pre-Workout Powder
